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ABSTRACT
Cerebral venous sinus thrombosis (CVST) is a rare condition. The most frequent symptoms and signs are headache, focal seizures 
with or without secondary generalization, unilateral or bilateral paresis and papilledema. We report a case of CVST in a 30-year-
old female that presented with headache, diminution of vision, swelling and pain in both eyes and bilateral restricted extraocular 
movements. She expired after 3 days of treatment as she was diagnosed late. Due to its diverse and varied clinical presentation, CVST 
should be considered as differential in almost any brain syndrome.
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Cerebral venous sinus thrombosis is a rare condition. Actual incidence of this condition is not exactly known. It has an estimated incidence of 5/1.000.000 [1]. Signs 
and symptoms of the disease consist of headache, focal and 
generalized convulsions, unilateral and bilateral paresis, and 
papilledema [2]. It’s important etiological factors are pregnancy, 
puerperium, oral contraceptive use, coagulopathies, intracranial 
infections, cranial tumours, lumbar puncture, malignancy, 
dehydration, inflammatory bowel disease, connective tissue 
disorders, Behcet’s disease, parenteral infusions, and various 
drugs. In 30% of the patients, the etiology cannot be determined 
[3]. Because this is potentially fatal condition, so early diagnosis 
and treatment is quiet important. In this paper, we aim to present 
a case of CVST which ended up with maternal mortality and was 
not diagnosed and treated well in time. 
CASE REPORT
A 30-year-old women, gravida 3 para 2 at 10 weeks of pregnancy, 
presented with sudden onset diminution of vision since last 4 
days. She was experiencing swelling and pain in left eye followed 
by involvement of right eye with same symptoms with restricted 
extraocular movements of both eyes in all gazes within 3-4 days. 
It was associated with headache, neck stiffness and fever with 
chills and rigor. Prior to reporting to our hospital, the patient 
went to a private clinic nearby where she was treated with IV 
antibiotics and oral analgesics. 
As the condition worsened in 3-4 days, the patient came to this 
institute. On asking past history, there was h/o recurrent pustule on 
lower lid sometimes on left or right eye since last 2 months which 
subsided with mild treatment from local practitioner. There was 
no history suggestive of facial sinus or dental infection and recent 
trauma. She had never experienced similar symptoms during her 
previous pregnancy and there was non-significant family history. 
On the day of presentation she was conscious, looking pale 
and lethargic, co-operative and well oriented to timeplace and 
person. On general physical examination, she was average built 
but dehydrated, her pulse was 132/minute, BP was 50/40mmHg, 
respiratory rate was 30/minute. On ocular examination, lid 
swelling was more tense in left eye as compared to right eye and 
chemosis was present in left eye. Perception of light was present 
in the right eye with projection of rays inaccurate while in the 
left eye perception of light was not present. Bilateral corneal 
sensations were absent, extra ocular movements were restricted 
in all gaze in both eyes (complete ophthalmoplegia). Pupils were 
mid-dilated and fixed in both eyes. Fundus examination showed 
bilateral papilledema. There were no peripheral neurological 
signs noted. 
Complete blood counts showed total leukocyte counts of 
18000 cells/uL, differential counts -88, 11, 1, 0, and haemoglobin 
of 8gm/%. Coagulation profile was normal. Liver function tests 
showed aspartate (SGOT) levels of 123 IU and alanine transferase 
(SGPT) of 76IU and renal function test showed creatine 1.8mg/
dL and urea of 46mg/dL. On radiological imaging, Magnetic 
resonance (MR) venography brain showed multiple acute infarcts 
in bilateral hemisphere and non-visualisation of left transverse 
sinus, sigmoid sinus and internal jugular vein suggestive of 
CVST (Fig. 1, 2). 
The patient was thus diagnosed as a case of gravida 3 para 
2 at 10 week gestation with anaemia and CVST (left transverse 
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and sigmoid sinus) with sepsis with shock. The patient was 
started on empirical IV antibiotics and IV anticoagulants (low 
molecular weight heparin 1mg/kg/bw in renal modified doses) 
along with intravenous fluids and vasopressor inj. She was 
given adrenaline and dopamine as the patient was in shock at 
the time of presentation. The patient showed mild improvement 
symptomatically initially for few hours after treatment. Her 
renal and liver parameters worsened next day. Her creatinine 
rose to 4.1mg/dL and SGOT and SGPT rose to 3240/3458 IU, 
respectively. Her prothrombin time rose to 22 seconds and INR 
rose to 2.3 and platelets decreased to 76000/uL. On 3rd day after 
treatment, patient’s condition worsened and she expired.
DISCUSSION 
Cerebral venous sinus thrombosis is a rarely seen entity which 
presents diagnostic difficulties, because of the variable nature of 
its clinical signs and symptoms. It occurs 10 to 13 times more 
often during the puerperium than during pregnancy and is also 
very rare during the first trimester. The most common postulated 
mechanism on how cerebral venous sinus thrombosis can affect 
a pregnant woman is hypercoagulable state brought about by 
the pregnancy itself and further aggravated by dehydration and 
anaemia [4]. 
The most commonly affected site is the transverse sinus, 
followed by superior sagittal sinus and straight sinus [5]. Other 
less common sites are the cortical vein, jugular vein and internal 
cerebral vein. In most of the patients, thrombosis occurs in more 
than one sinus. The mode of onset is highly variable, which 
can be from sudden to progressive over weeks, so it can mimic 
other conditions such as tumour, stroke, or benign intracranial 
hypertension. Headache, focal deficits, seizures, disorders of 
consciousness, and papilledema, which can present in isolation 
or in association, are the most frequent signs [6,7]. Loss of 
consciousness is a sign of poor prognosis which is associated 
with higher mortality rates [8]. 
Radiological examination plays an important role in the 
diagnosis of CVST. MR Venography is the investigation of 
choice. According to the guidelines of the European Federation 
of Neurological Societies, the first line treatment for cerebral 
venous and Dural sinus thrombosis is anti-thrombolytic agents. 
The antithrombotic treatment favours spontaneous thrombus 
resolution and to recanalize the occluded vein or sinus, to avoid 
thrombus propagation, and to prevent complications such as 
pulmonary thromboembolism. 
In the acute treatment of CSVT, heparin (intravenous or 
subcutaneous), and in the maintenance therapy, warfarin are 
recommended. The optimal duration of oral treatment varies, but 
the accepted practice is 3 months for idiopathic cases, between 
3 and 6 months for pregnancy related cases or and between 6 
and 12 months in patients with hereditary thrombophilia [9]. The 
prognosis is usually good in patients with obstetric causes and has 
a mortality rate between 5 and 10% [5,10]. Unfortunately, in this 
case patient was not diagnosed and treated early.
CONCLUSIONS
Due to its diverse and varied clinical presentation, cerebral 
venous sinus thrombosis should be considered in almost any 
brain syndrome. Outcome depends on early suspicion and urgent 
treatment as the condition can be reversed.
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